Navigation Links
PuraMed BioScience Sponsors Miles for Migraine Race with LipiGesic M
Date:8/22/2013

SCHOFIELD, Wis., Aug. 22, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it will sponsor the 5th Miles for Migraine Race San Francisco by supplying $5,000 of LipiGesic M for the participants.

Miles for Migraine, a registered 501c3 nonprofit, will host the 5th Miles for Migraine race on September 14, 2013 in San Francisco. "We are honored to be part of the effort to increase the awareness of migraine," said Russ Mitchell, CEO PuraMed BioScience. "Miles for Migraine and PuraMed BioScience share the same goal: to improve the lives of people who suffer with migraine. It's a great fit.

"We hope that we will not only help increase awareness, but also hope that by donating LipiGesic M that we will give the runners a tool for migraine treatment that stops migraine pain," said Mitchell.

LipiGesic M is a homeopathic formulation of feverfew and ginger delivered in a sublingual gel. Clinical trial results show that LipiGesic M has an efficacy rate that exceeds the number-one-selling triptan medication. In addition, LipiGesic M has not been shown, in the clinical trial or in everyday use, to cause drowsiness or rebound headache even if a migraineur takes the medication frequently.

"More people suffer from migraine than diabetes and asthma combined; yet it receives a fraction of funding for research," said Miles for Migraine Executive Director Joanne Fedeyko. "With local and national growth key to our mission of raising awareness, I'm thrilled San Francisco will once again host Miles for Migraine and help spread the word that migraine is more than 'just a headache.' With one in four American families impacted by migraine, we know that there is a huge population to get behind our cause."

Migraine is the leading brain disorder in the United States. Over 50 million American adults, teens, and children suffer from migraines or sinus headaches, which are often misdiagnosed migraines. In a 2004 report, the World Health Organization (WHO) classified severe migraine in the same category of disability with quadriplegia or terminal stage cancer.

General Event Information for 2013
The 5th Miles for Migraine San Francisco race takes place on Saturday September 14th at 8 a.m. in Golden Gate Park, in San Francisco, California. Fees range from $31 for the 2-Mile Walk to $41 for the 10K. Register online at www.milesformigraine.org

Forward-Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Patricia McMurtrie, VP Marketing
715-571-4910
patricia@PuramedBioScience.com
www.PuramedBioScience.com


'/>"/>
SOURCE PuraMed BioScience, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PuraMed BioScience Discusses Potential for Patent Portfolio Acquisition
2. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
4. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
5. Neurocrine Biosciences Reports First Quarter 2012 Results
6. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
7. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
8. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
9. HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park
10. Tethys Bioscience and Lose it! Announce a Strategic Partnership to Support Diabetes Prevention
11. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... 10, 2017 Radiology has become the number ... have also spiraled to the number one ranking as ... than ever before as the most complete and reliable ... with lower back pain an MRI may confirm a ... pain, resulting in entirely different treatment protocols.  In these ...
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, ... provides technology solutions to improve the clinical effectiveness ... results for the first quarter ended March 31, ... products enable our customers to identify when preventive ... intervene before events like heart attacks or strokes ...
(Date:5/6/2017)...  Hill-Rom Holdings, Inc. (NYSE: HRC), has begun a ... to its Welch Allyn campus. The ... more than 100 new jobs to Central ... a significant presence for more than 100 years. Hill-Rom,s ... large portion of which will be R&D and engineering ...
Breaking Medicine Technology:
(Date:5/21/2017)... , ... May 21, 2017 , ... ... it's been longer than six months since you've seen a dentist, it's time ... per year and getting x-rays once per year. , Dental checkups are a ...
(Date:5/19/2017)... ... May 19, 2017 , ... When Kyle Busch graduates ... name will already appear on two major research studies that could impact the health ... Dr. Matt Daggett, KCU alumnus and an orthopedic surgeon, alongside an international team trying ...
(Date:5/19/2017)... ... May 19, 2017 , ... ... class of Beckman Young Investigators: , Victor Acosta, Ph.D. - University of New ... Dan Fu, Ph.D. - University of Washington, Erik Grumstrup, Ph.D. - Montana Stata ...
(Date:5/19/2017)... ... May 18, 2017 , ... CloSYS products which are marketed as the gentle ... for mouth and gum health, which is linked to one’s overall health. Since 1991 ... of the powerful ways in which CloSYS products immediately helped eliminate bad breath as ...
(Date:5/18/2017)... ... May 18, 2017 , ... Originally launched to market as the ... Tab. Due to the rapid expansion of their product line, the company believed it ... Now, the HighQ brand will be any tablet product sold by EPIK Learning. ...
Breaking Medicine News(10 mins):